Search Results - "Hepatocellular carcinoma"

Chemical Characterization of Pollen Grains Ethanolic Extract (PGE) with Evaluation of its Potent Antioxidant, Antibacterial and Anti-Cancer Activities against Hepatocellular Carcinoma (HepG2).

Authors: Al-Thubaiti, Eman H. Hamza, Reham Z. Alaidaroos, Bothaina A. et al.

Source: Indian Journal of Animal Research. Oct2025, Vol. 59 Issue 10, p1653-1662. 10p.

Subjects: Antioxidants, Hepatocellular carcinoma, Pollen, Antineoplastic agents, Flavonoids, Antibacterial agents, Plant extracts, Analytical chemistry

Computed tomographic findings of splenic metastasis of hepatocellular carcinoma in a dog.

Alternate Title: Résultats tomodensitométriques de métastases spléniques d'un carcinome hépatocellulaire chez un chien.

Authors: Jeongyun Jeong Jupill Chang Seunghee Lee et al.

Source: Canadian Veterinary Journal / Revue Vétérinaire Canadienne. Aug2025, Vol. 66 Issue 8, p862-867. 6p.

Subjects: Hepatocellular carcinoma, Metastasis, Dogs, Multidetector computed tomography, Histopathology, Computed tomography, Chemoembolization

Perioperative camrelizumab plus rivoceranib versus surgery in resectable hepatocellular carcinoma.

Authors: Kaseb, Ahmed Pawlik, Timothy M

Source: Lancet. Nov2025, Vol. 406 Issue 10515, p2035-2038. 4p.

Subject Terms: SURGERY, HEPATOCELLULAR carcinoma, ANTINEOPLASTIC agents, IMMUNE checkpoint inhibitors, PERIOPERATIVE care

Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial.

Authors: Wang, Zheng Fan, Jia Zhou, Shaolai et al.

Source: Lancet. Nov2025, Vol. 406 Issue 10515, p2089-2099. 11p.

Subject Terms: HEPATOCELLULAR carcinoma, SURGERY, PERIOPERATIVE care, RANDOMIZED controlled trials, DISEASE relapse, NEOVASCULARIZATION inhibitors, IMMUNE checkpoint inhibitors, PROGRESSION-free survival

Geographic Terms: CHINA

Formulation, characterization, and In vitro evaluation of lenvatinib-loaded solid lipid nanoparticles functionalized with Twenty-Polyglycerol vitamin E succinate for liver cancer treatment.

Authors: Zhou, Yanyan Luo, Shengnan Jiang, Zhe et al.

Source: Drug Development & Industrial Pharmacy. Nov2025, Vol. 51 Issue 11, p1528-1541. 14p.

Subject Terms: HEPATOCELLULAR carcinoma, NANOPARTICLES, CONTROLLED release preparations, CYTOTOXINS, VITAMIN E, NANOMEDICINE, ANTINEOPLASTIC agents, DRUG delivery systems

Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients

Authors: Arendt, Nathalie Kopsida, Maria Khaled, Jaafar et al.

Source: Therapeutic Advances in Medical Oncology. 17:1-30

Subject Terms: abdominal pain, chemotherapy agents, diarrhea, gastrointestinal side effects, GI toxicity, hepatocellular carcinoma, nausea, transarterial chemoembolization

File Description: electronic

Access URL: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-551435
https://doi.org/10.1177/17588359251316663

The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment.

Authors: Chan, Stephen Lam Sun, Hui-Chuan Xu, Yang et al.

Source: Lancet. Aug2025, Vol. 406 Issue 10504, p731-778. 48p.

Subject Terms: HEPATOCELLULAR carcinoma

Deciphering the cytotoxic potential of acamprosate and acamprosate loaded mesoporous silica nanoparticles in hepatocellular carcinoma: an in vitro and in silico approach.

Authors: Bhat, Suhail Ahmad Chandramohan, Sathyapriya Subramanian, Srividya et al.

Source: Drug Development & Industrial Pharmacy. Sep2025, Vol. 51 Issue 9, p1044-1063. 20p.

Subject Terms: HEPATOCELLULAR carcinoma, MESOPOROUS silica, CYTOTOXINS, IN vitro studies, ANTINEOPLASTIC agents, DRUG delivery systems, APOPTOSIS

Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance.

Authors: Shin, Hun Kyeong Chung, Hea Ji Kim, Wan Hee

Source: Veterinary & Comparative Oncology. Dec2024, Vol. 22 Issue 4, p490-499. 10p.

Subjects: Hepatocellular carcinoma, Overall survival, Immunohistochemistry, Cell proliferation, Tissue analysis

Deciphering the rules of disulfidptosis: a genome-wide signature for identifying disulfidptosis-related genes and analyzing hepatocellular carcinoma chemotherapy sensitivities.

Authors: Zhang, Yi Guo, Ying He, Wenxi et al.

Source: Free Radical Biology & Medicine. Dec2025, Vol. 241, p914-932. 19p.

Subject Terms: *HEPATOCELLULAR carcinoma, *CANCER treatment, *GENES, *CELL death, *SMALL molecules, *TRANSCRIPTION factors

MRI major and ancillary features of LI-RADS for diagnosis of pediatric malignant liver tumors.

Authors: Choi, Se Jin Shin, Jeong In Kim, Pyeong Hwa et al.

Source: European Radiology. Dec2025, Vol. 35 Issue 12, p7688-7700. 13p.

Subject Terms: *LIVER tumors, *HEPATOCELLULAR carcinoma, *STATISTICAL accuracy, *PEDIATRICS, *DIAGNOSIS, *SENSITIVITY & specificity (Statistics), *MAGNETIC resonance imaging

Evaluation of the LI-RADS radiation treatment response assessment v2024 in comparison with the modified RECIST.

Authors: Kim, Hokun Kim, Bohyun Son, Seok Hyun et al.

Source: European Radiology. Dec2025, Vol. 35 Issue 12, p7549-7559. 11p.

Subject Terms: *HEPATOCELLULAR carcinoma, *OVERALL survival, *DIAGNOSTIC imaging, *RADIOTHERAPY, *TREATMENT effectiveness, *RADIOEMBOLIZATION

MR elastography-based prediction of development of hepatocellular carcinoma in patients with chronic hepatitis B with sustained virological response.

Authors: Chen, Haimei Zhu, Jie Zhou, Jinhui et al.

Source: European Radiology. Dec2025, Vol. 35 Issue 12, p8032-8045. 14p.

Subject Terms: *HEPATOCELLULAR carcinoma, *CHRONIC hepatitis B, *DISEASE risk factors, *ELASTOGRAPHY, *EARLY diagnosis, *NONINVASIVE diagnostic tests, *PREDICTIVE validity

Multi-omics dissection of RAD21-PON1 axis reveals metabolic-immune crosstalk and prognostic significance in hepatocellular carcinoma.

Authors: Liu, Zhe Liu, Fang Yao, Zhongyu et al.

Source: Mammalian Genome. Dec2025, Vol. 36 Issue 4, p1291-1315. 25p.

Subject Terms: *HEPATOCELLULAR carcinoma, *PARAOXONASE, *PROGNOSIS, *TUMOR microenvironment, *CELL communication, *MULTIOMICS, TUMOR genetics

Cordyceps sinensis mycelium Refined Polysaccharides Regulate PI3K/AKT/mTOR Pathway to Inhibit Hepatocellular Carcinoma and its Synergistic Effect on Cyclophosphamide.

Authors: Sui, Guochen Zhang, Zhuoran Tian, Xuejun et al.

Source: Pharmacognosy Magazine. Dec2025, Vol. 21 Issue 4, p1519-1529. 11p.

Subject Terms: *HEPATOCELLULAR carcinoma, *PI3K/AKT/MTOR pathway, *TUMOR suppressor genes, *POLYSACCHARIDES, *CYCLOPHOSPHAMIDE, *APOPTOSIS, *CHINESE medicine

The post-surgical liver: is application of treatment response assessment within the CEUS LI-RADS framework possible?

Authors: Samuel, Anna S. Qiao, Andee Merrill, Christina D. et al.

Source: Abdominal Radiology. Dec2025, Vol. 50 Issue 12, p5761-5773. 13p.

Subject Terms: *CONTRAST-enhanced ultrasound, *HEPATOCELLULAR carcinoma, *LIVER surgery, *LIVER cancer, *DISEASE relapse, *SURGICAL margin, *LIVER analysis, *TREATMENT effectiveness

METTL3-Mediated m6A Methylation of USP21 Contributes to Hepatocellular Carcinoma Progression by Stabilizing H2BFS Through Deubiquitination.

Authors: Yao, Peng Li, Xiaozheng Chai, Jiasui et al.

Source: Biochemical Genetics. Dec2025, Vol. 63 Issue 6, p5462-5479. 18p.

Subject Terms: *HEPATOCELLULAR carcinoma, *DEUBIQUITINATING enzymes, *PROTEINS, *CANCER invasiveness, *METHYLTRANSFERASES, *CELL proliferation, *RNA methylation

Circ_0000972 Inhibits Hepatocellular Carcinoma Cell Stemness by Targeting miR-96-5p/PFN1.

Authors: Tang, Jintian Tang, Runjuan Xue, Feng et al.

Source: Biochemical Genetics. Dec2025, Vol. 63 Issue 6, p5175-5192. 18p.

Subject Terms: *HEPATOCELLULAR carcinoma, *CANCER stem cells, *MICRORNA, *PROFILIN, *XENOGRAFTS, *TUMOR growth, *CELLULAR control mechanisms, *CIRCULAR RNA

Clinical Outcomes of Reduced‐Dose Cabozantinib as Third‐ or Later‐Line Therapy After Immune Checkpoint Inhibitors in Advanced Hepatocellular Carcinoma: A Real‐World Study.

Authors: Kuzuya, Teiji Muto, Hisanori Tachi, Yoshihiko et al.

Source: Hepatology Research. Nov2025, p1. 12p. 6 Illustrations.

Subject Terms: *HEPATOCELLULAR carcinoma, *IMMUNE checkpoint inhibitors, *TREATMENT effectiveness, *PROGRESSION-free survival, *SCIENTIFIC observation, *CANCER treatment

Multiplexed Transcriptomics for Screening Drug Combinations and Defining the Mechanism of Action of HCC Therapeutics at Single‐Cell Resolution.

Authors: Jiang, Mengmeng Chen, Haide Wen, Guoxia et al.

Source: Cell Proliferation. Nov2025, p1. 15p. 5 Illustrations.

Subject Terms: *HEPATOCELLULAR carcinoma, *COMBINATION drug therapy, *CELL analysis, *TRANSCRIPTOMES, *CELL death, *GENE regulatory networks, *HIGH throughput screening (Drug development), *CANCER cell proliferation